<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title></title></head><body><div><p style="margin:0pt; text-align:center"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Written evidence from MSD</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">-UK Ltd (LTC 24)</span><br /><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><h1 style="margin:0pt 7.1pt 0pt 0pt; page-break-after:avoid; page-break-inside:avoid"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">At MSD-UK, we believe the most important thing we make is a difference.</span></h1><p style="background-color:#ffffff; margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">operate in more than 140 countries and through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products we work with customers to bring innovative healthcare solutions to those who need them the most. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programmes and partnerships. </span></p><p style="background-color:#ffffff; margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">MSD is a trade name of Merck &amp; Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">MSD has been based in the UK for more than 80 years:</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 13.36pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We are a significant provider to the NHS</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 13.36pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We invest many millions of pounds in our UK facilities, including our laboratories in Hoddesdon which are a world-wide centre of excellence in chemistry</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 13.36pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The UK is also home to one of MSD’s most important manufacturing facilities outside of the US, producing tablets for worldwide markets</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 13.36pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We have the largest veterinary production facility in the UK</span></li><li style="background-color:#ffffff; font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 13.36pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We employ more than 2,000 people across four UK sites.</span></li></ul><p style="background-color:#ffffff; margin:0pt 0pt 0pt 21.3pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Executive Summary </span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Despite improvement in the last decade, more can be done to manage long-term conditions in the UK, for example </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> lags behind European counterparts in improving CVD mortality rates. </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Inequalities and variation in long-term condition mortality rates &amp; access to care remain across the UK.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Proactively addressing </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">long-term condition risk factors more robustly in the community-setting,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> such as </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Cardiovascular Disease and Type 2 diabetes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> has the potential to deliver a more ‘effective’ NHS service</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> (e.g. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">EiP</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> Greenw</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ich case-study)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This should be </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">driven</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> through measures that encourage quality </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> can deliver overall cost-efficiency in the NHS, rather than short-term cost-savings with potential unintended consequences</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">It is critical that we align how we measure and incentivise health-care professionals (&amp; NHS England bodies</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">) with national </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">clinical guidelines on long-term condition risk factor manage</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ment</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in o</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rder to address mortality rates, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">quality of life</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and costly complications</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Quality measures need to go beyond ‘testing’ alone to ensure </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">long-term conditions and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">risk factors are being effectively addressed nationwide and to further narrow inequalities.</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">With the creation of NHS England and the removal of certain information &amp; education structures (e.g. NHS diabetes) it is key that new support structures are adopted rapidly in order to offer practical assistance to commissioners. </span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are a number of examples of effective integration of services across health, social care and other services which treat and manage long-term conditions (e.g. First Diabetes (Derbyshire), </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">EiP</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> Greenwich case-study)</span></li><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 10.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">With an increasing ageing population it is key that more is done to address disease management of long-term conditions </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in the community-setting </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">in order to improve mortality rates, quality of life and prevent costly hospital admissions and care. This should be supported by appropriate measurement and outcome indicators that are focussed on long-term savings not solely short-term savings.</span></li></ul><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">We welcome the Health Select Committee’s inquiry into the Management of Long-Term Conditions.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The points we would like to raise are as follows:</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Despite improvement</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> in the last decade,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> more can be done to manage long-term conditions in the UK, for example </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">lags behind European counterparts in improving</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> CVD mortality rates.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">1.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Although significant improvements in the prevention and treatment of CVD over the last decade have been made, CVD remains one of the largest causes of</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> death and disability in the UK</span><a name="_ftnref1"></a><a href="#_ftn1">[1]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">1.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The Global Burden of Disease Study demonstrates</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> could do better i</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">n improving CVD mortality rates</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in comparison with other European countries</span><a name="_ftnref2"></a><a href="#_ftn2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">1.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">It is estimated that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">that there are approximately 2.5</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> million people diagnosed with Type 2 diabetes </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> up to 850,000 undiagnosed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> in the UK</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">3</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">1.4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The recent DUK State of the Nation report highlights that only </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">half of people with Type 2 diabetes get the annual tests and investigations that are recommended in the national standards. Importantly</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> even where testing is taking place</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> many patients are not achieving the recommended target range for risk factors</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> More must be done to address this</span><a name="_ftnref3"></a><a href="#_ftn3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Inequalities and variation in mortality rates &amp; access to care remain across the UK. </span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A wide variation in the treat</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ment and management of diabetes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> across England </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">remains</span><a name="_ftnref4"></a><a href="#_ftn4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super"> </span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There are geographical inequalities across the UK in CHD mortality and this is often worse in areas of highest deprivation</span><a name="_ftnref5"></a><a href="#_ftn5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Another example of a national health inequality exists in the diagnosis and management of Familial Hypercholesterolaemia (FH) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">or ‘inherited high cholesterol’ across the devolved nations</span><a name="_ftnref6"></a><a href="#_ftn6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.4.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The recent NHS Information Centre on the ‘Use of NICE appraised medicines in the NHS in England -2010 and 2011, Experimental Statistics</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">’</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> showed that there was a variation in utilisation of medicines for long-term conditions. For example</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ratio of observed to expected usage of a NICE-approved </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">non-statin </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">cholesterol management therapy in the London SHA was approximately 0.6 in 2010 and 0.55 in 2011 versus nearly 0.9 in 2010 and nearly 0.8 in 2011 in the South East Coast SHA</span><a name="_ftnref7"></a><a href="#_ftn7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">2.5.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Access restrictions to NICE approved medicines remains a problem at local formulary level, which can lead to postcode prescribing which reinfo</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rces healthcare inequalities</span><a name="_ftnref8"></a><a href="#_ftn8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Proactively addressing long-term condition risk factors more robustly in the community-setting, such as for Cardiovascular Disease and Type 2 diabetes, has the potential to deliver a more ‘effective’ NHS service. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">This should be </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">driven</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> through measures that encourage quality </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> can</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> deliver overall cost-efficiency in the NHS</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">, rather than short-term cost-savings with potential unintended consequences</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">.</span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NHS spending on diabetes was almost £10 billion in 2011, which was 10 per cent of the NHS budget. 80 per cent of NHS spending on diabetes goes into managing avoidable complications. People with diabetes account for around 19 per cent of hospital inpatients at any one time, and have a three day longer stay on average than people without diabetes. Most of type 2 diabetes c</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">osts are due to hospitalisation.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">3</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">More effective risk factor management in the community has the potential to reduce costs to the NHS</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, while </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">improving quality of care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.2.1.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Evidence into Practi</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ce (</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">EiP</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">) is a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> clinical change manag</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ement programme</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. The </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">programme</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">aims to ensure that people with diabetes and those at increased cardio-metabolic risk receive </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">optimal care</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> through the effective implementation of national policy and guidelines, particularly NICE Type 2 Diabetes Guidelines</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">An example of the success of this approach was demonstrated in Greenwich. R</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">esults after one year show</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> that in practices who took up the programme </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> significant improve</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ment in patients achieving NICE-recommended</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> risk factor targets </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">were</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> achieved </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and substantial </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">overall cost-</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">savings</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">were demonstrated </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">due to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a reduction in hospital admission rates</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. NICE have endorsed EiP as a proven case study for QIPP. NICE concluded that the programme scored 100% for evidence of change and 75% fo</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">r both savings made and quality.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">This approach e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">nabl</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ed</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> the delivery of higher standards of care at</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> a lower overall cost to the NHS</span><a name="_ftnref9"></a><a href="#_ftn9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, current national QIPP</span><a name="_ftnref10"></a><a href="#_ftn10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> standards </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">often</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> focus on short-term drug budget savings </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">through prescribing indicators </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rather than</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> encouraging</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> optimising medicines in line with NICE quality standards, guidelines and recommendations.</span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.3.1.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">For example, although the NICE Type 2 Diabetes guideline (CG</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">87</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">)</span><a name="_ftnref11"></a><a href="#_ftn11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> outlines a number of treatment pathways based on</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> individual patient profile utilising older and newer therapies appropriately, the QIPP prescribing comparator for diabetes is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">solely </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">based on the use of low cost drugs relative to newer therapies</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.3.2.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Medicine optimisation is about ensuring the right patients get the right choice of medicine at the right time and how patients comply. </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">National measure of quality such as QIPP </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">prescribing comparators </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and other outcome indicators </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">should be focussed around NICE</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> quality standards and guidance</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rather than</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> stand-alone</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">comparators that may encourage </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">short-term savings that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">could</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> have unintended</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> costly</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> consequences.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">It is critical that we</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> alig</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">n</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> how we </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">measure and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">incentivise health-care professionals</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">(</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&amp;</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> NHS England</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">bodies</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> with</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> national </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">clinical </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">guidelines on </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">long-term condition </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">risk factor management</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">in order to address mortality</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> rates</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> quality of life</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">.</span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">4.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Inconsistencies exist in national guidance for treating patients and how GPs are incentivised</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">4.1.1.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">For example, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">In </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NICE </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Type 2 Diabetes Guideline (</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">CG</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">87)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">11</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">it</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> states, “</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">Consider intensifying cholesterol-lowering therapy (with a more effective statin or</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic"> cholesterol absorption inhibitor) in line with NICE guidance</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic"> if there is existing or newly diagnosed cardiovascular disease, or if there is an increased albumin excretion rate, to achieve a total cholesterol level below 4.0 mmol/litre (and HDL cholesterol not exceeding 1.4 mmol/litre) or an LDL cholesterol level below 2.0 mmol/litre.”</span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">4.1.2.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">However, the Quality Outcomes Framework </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">that incentivises</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> GP states: The percentage of patients with diabetes, on the register, whose last measured total cholesterol (measured within the preceding 12 months) is 5 mmol/l or less and has an activity threshold of 40-75%</span><a name="_ftnref12"></a><a href="#_ftn12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">4.1.3.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The European Society of Cardiology/European Atherosclerosis Society Guidelines are even more stringent than</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> UK </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NICE </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">guidelines </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for very high risk patients</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">they recommend </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">an LDL-C goal of 1.8 mmol/litre and/or 50% reduction when target level cannot be reached</span><a name="_ftnref13"></a><a href="#_ftn13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 99pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">4.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The impact </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">of factors </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">on quality of life &amp; productivity </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">(such as </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">potential </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">impact of </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">hypoglycaemia in Type 2 diabetes) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">should </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">be </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">recognised</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, researched</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and acknowledged within NHS measures </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">of long-term condition management </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">quality </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">throughout the system</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 61.2pt; text-indent:-25.2pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">4.2.1.</span><span style="font:7.0pt 'Times New Roman'"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">For example, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">DVLA guidelines</span><a name="_ftnref14"></a><a href="#_ftn14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">state </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">for people with </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">diabetes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">when treated with medication other than insulin which carries a risk of inducing hypoglycaemia (including sulphonylureas and gl</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">inides), the following standard</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">applies in order to retain a driving </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">licenc</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e:</span></p><p style="margin:0pt 0pt 0pt 54pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic; font-weight:bold">Class 2 Drivers (buses and lorries)</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 46.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There has not been any severe hypoglycaemic event in the previous 12 months </span></li></ul><p style="margin:0pt 0pt 0pt 54pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic; font-weight:bold">Class 1 Drivers (cars and motorcycles)</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:11pt; margin:0pt 0pt 0pt 46.06pt; padding-left:7.94pt; text-indent:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Must not have had more than one episode of severe hypoglycaemia </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">within the preceding 12 months</span></li></ul><p style="margin:0pt 0pt 0pt 54pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The impact of hypoglycaemia on a person who is a professional driver or who drives regularly could be very significant on both quality of life and productivity</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> if </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">hypoglycaemia leads to losing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> their licenc</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Similarly, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">i</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">n the elderly</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> e</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ven a mild episode of hypoglycaemia may lead to adverse outcomes in frail elderly patients. For example, episodes of dizziness or weakness increase the risk of falls and fracture</span><a name="_ftnref15"></a><a href="#_ftn15">[15]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">The </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">NICE Quality Standard for Diabetes</span><a name="_ftnref16"></a><a href="#_ftn16">[16]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> recognises the importance of hypoglycaemia and includes a measure that states:</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">‘People with diabetes who have experienced hypoglycaemia requiring medical attention are referred to a specialist diabetes team’</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Quality measures recognising factors such as h</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ypoglycaemia monitoring </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and/</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">or management</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">should </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">also </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">be</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> incentiv</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">ised in QOF and</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> CCG Outcome Indicators</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">              </span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">Quality measures need to go beyond </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">‘</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">testing</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">’</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">alone </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">to ensure risk factors are being effectively addressed </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">nationwide </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">and to further narrow inequalities</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">.</span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">5.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">lthough testing, such as the 9 Key Care Processes for Diabetes</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">, are important</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> testing alone cannot make a difference to outcome, healthcare professionals need to ensure action is taken on the results of tests to ensure that people’s </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">long-term condition</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> and risk-factors are being managed effectively</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">3</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. Quality measures and outcome indicators throughout the NHS system </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">(e.g. CCG outcome indicators) </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">should reflect this.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">5.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">For example in diabetes,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> even where testing is taking place, many patients are not achieving the recommended target range for risk factors (e.g. although 90% of Type 2 Diabetes patients are having their HbA1c and cholesterol tested, only 60% are achieving target HbA1c levels and only 40% are achieving their target cholesterol level in England)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">3</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">5.3.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Access to education of the patient</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">and care planning </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">is of paramount importance</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">3</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">A patient should be informed and enabled to take a role in self-management of diabetes risk-factors and understand factors such as the importance of optimal blood glucose control in order</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> to avoid serious complications.</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">With the creation of NHS England and the </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">removal</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> of certain information &amp; education structures</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">(e.g. NHS diabetes)</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold"> it is key that new </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">support </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">structures are adopted rapidly in order to </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">offer practical assistance to commissioners</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">. </span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">6.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">With the dissolution of NHS Diabetes, there is a gap in support &amp; education for development of commissioning for diabetes services at the very time when it is most needed. </span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">6.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">There </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">are</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> a wide number of data sets available for CVD and diabetes but they are often difficult to interpret and support is required on how to utilise these and help in practical implementation of commissioning</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 18pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">There are a number of examples of effective integration of services across health, social care and other services which treat and manage long-term conditions</span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">7.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">First Diabetes (Derbyshire) is a current of example of how integrated care can provide real improvements in care for diabetic patients, whist reducing admission rates</span><a name="_ftnref17"></a><a href="#_ftn17">[17]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">7.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">See </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">earlier example of EiP</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:7.33pt; vertical-align:super">9</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> example, paragraph </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">3.2.1</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><a name="_GoBack"></a></p><p style="margin:0pt 0pt 0pt 36pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold; list-style-position:inside; margin:0pt; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">With an increasing ageing population it is key that more is done to address disease management of long-term conditions </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">in the community-setting </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">in order to improve mortality rates, quality of life and prevent costly hospital admissions and care. This should be supported by appropriate mea</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">surement and outcome indicators</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">.</span></li></ol><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">8.1.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">Diabetes cost approximately £ 23.7bn in the UK in 2010/2011: £ 9.8bn in direct costs (£1bn for Type 1 diabetes and £ 8.8bn for Type 2 diabetes) and £ 13.9bn in indirect costs (£ 0.9bn and £ 13bn). In real terms, the 2035/2036 cost is estimated at £ 39.8bn: £ 16.9bn in direct costs (£ 1.8bn for Type 1 diabetes and £ 15.1bn for Type 2 diabetes) and £ 22.9bn in indirect costs (£ 2.4bn and £ 20.5bn</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">)</span><a name="_ftnref18"></a><a href="#_ftn18">[18]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 39.6pt; text-indent:-21.6pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">8.2.</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">It is key that </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">there is </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">a shift in focus </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">from short-term cost-cutting in the community-setting </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">to more efficient use of NHS resources</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">by effective</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> prevention,</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> diagnosis and </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">risk-factor </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">management to avoid costly complications and hospital treatment</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">.</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt"> This should be supported by appropriate measu</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt">rement and outcome indicators.</span></p><p style="margin:0pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 10pt"><span style="font-family:'Frutiger LT Std 45 Light'; font-size:11pt; font-style:italic">May 2013</span></p><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div><hr style="width:33%; height:1px; text-align:left" /><p style="margin:0pt"><a name="_ftn1"></a><a href="#_ftnref1">[1]</a><span style="font-family:Calibri; font-size:10pt"> </span><span style="font-family:Calibri; font-size:10pt">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/141273/9387-2900853-CVD-Outcomes_web1.pdf.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn2"></a><a href="#_ftnref2">[2]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60355-4/abstract (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn3"></a><a href="#_ftnref3">[3]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.diabetes.org.uk/Documents/Reports/State-of-the-Nation-2012.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn4"></a><a href="#_ftnref4">[4]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> www.rightcare.nhs.uk/index.php/atlas/diabetes (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn5"></a><a href="#_ftnref5">[5]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> www.heartuk.org.uk/latest-news/article/cholesterol-and-a-healthier-nation(last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn6"></a><a href="#_ftnref6">[6]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Saving Lives, Saving Families. The health, social and economic advantages of detecting and treating familial </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">hypercholesterolaemia</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">. HEART UK.</span></p><p style="margin:0pt"><a name="_ftn7"></a><a href="#_ftnref7">[7]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.data.gov.uk/dataset/use-of-nice-appraised-medicines-in-the-nhs-in-england-2010-and-2011-experimental-statistics (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn8"></a><a href="#_ftnref8">[8]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.pulsetoday.co.uk/gps-face-bans-on-high-cost-drugs/12198831.article (last accessed 9May 2013)</span></p><p style="margin:0pt"><a name="_ftn9"></a><a href="#_ftnref9">[9]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> https://www.evidence.nhs.uk/document?ci=http%3A%2F%2Farms.evidence.nhs.uk%2Fresources%2FQIPP%2F899089&amp;q=Evidence%20into%20Practice&amp;ReturnUrl=%2Fsearch%3Fom%3D%255B%257B%2522srn%2522%253A%255B%2522%2Bqipp%2B%2522%255D%257D%255D%26q%3DEvidence%2Binto%2BPractice (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn10"></a><a href="#_ftnref10">[10]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.hscic.gov.uk/media/1354/QIPP-Prescribing-Comparators-Description-andSpecification/pdf/QIPP_Comparators_Description_and_Specification_V10.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn11"></a><a href="#_ftnref11">[11]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.nice.org.uk/CG87 (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn12"></a><a href="#_ftnref12">[12]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> ww.bma.org.uk/-/media/Files/PDFs/.../Contracts/gpqofguidance20132014.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn13"></a><a href="#_ftnref13">[13]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> www.escardio.org/guidelines-surveys/esc-guidelines/guidelinesdocuments/guidelines-dyslipidemias-ft.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn14"></a><a href="#_ftnref14">[14]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.dft.gov.uk/dvla/medical/Annex%203%20changes%20to%20diabetes.aspx (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn15"></a><a href="#_ftnref15">[15]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> Marker JC, </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">Cryer</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> PE, Clutter WE. Attenuated glucose recovery from </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">hypoglycemia</span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> in the elderly. Diabetes 1992; 41: 671-678</span></p><p style="margin:0pt"><a name="_ftn16"></a><a href="#_ftnref16">[16]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> http://www.nice.org.uk/media/FCF/87/DiabetesInAdultsQualityStandard.pdf (last accessed 9 May 2013)</span></p><p style="margin:0pt"><a name="_ftn17"></a><a href="#_ftnref17">[17]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> </span><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt">http://firstdiabetes.co.uk/awards-and-achievements</span></p><p style="margin:0pt"><a name="_ftn18"></a><a href="#_ftnref18">[18]</a><span style="font-family:'Frutiger LT Std 45 Light'; font-size:9pt"> 18 Hex et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine ª 2012 Diabetes UK</span></p></body></html>